AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Cash on Hand 2019–2025
AbCellera Biologics Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- AbCellera Biologics Inc. cash on hand as of December 31, 2025: 128.5M, a 17.79% decrease year-over-year.
- AbCellera Biologics Inc. cash on hand for 2025 were 128.5M, a 17.79% decrease from 2024.
- AbCellera Biologics Inc. cash on hand for 2024 were 156.3M, a 17.26% increase from 2023.
- AbCellera Biologics Inc. cash on hand for 2023 were 133.3M, a 65.51% decrease from 2022.
- AbCellera Biologics Inc. cash on hand for 2022 were 386.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AbCellera Biologics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $129 |
| 2024 | $156 |
| 2023 | $133 |
| 2022 | $387 |
| 2021 | $476 |
| 2020 | $594 |
AbCellera Biologics Inc. Cash on Hand — FAQ
AbCellera Biologics Inc. (ABCL) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's cash on hand history?
The chart and table above show AbCellera Biologics Inc.'s cash on hand by year and by quarter, including the growth rate.